Regulation of Histone Acetylation in the Nucleus by Sphingosine-1-Phosphate

Epigenetic Signals The lipid sphingosine-1-phosphate (S1P) is a signaling molecule that binds to receptors on the cell surface to initiate biochemical changes that control a range of biological processes from growth and survival to immune reactions. Hait et al. (p. 1254) report that S1P can also function by direct binding to the nuclear enzymes, histone deacetylases (HDACs) 1 and 2. The enzyme that generates S1P, sphingosine kinase 2 (ShpK2) is present in the nucleus in complexes with HDAC1 and HDAC2. Generation of S1P and its binding to HDACs inhibited deacetylation of histone. Such histone modification is an epigenetic mechanism that controls gene transcription. Thus, generation of S1P in the nucleus appears to be a signaling mechanism by which cells can control gene expression in response to various stimuli. A phospholipid that binds to nuclear enzymes modifies gene transcription in response to external stimuli. The pleiotropic lipid mediator sphingosine-1-phosphate (S1P) can act intracellularly independently of its cell surface receptors through unknown mechanisms. Sphingosine kinase 2 (SphK2), one of the isoenzymes that generates S1P, was associated with histone H3 and produced S1P that regulated histone acetylation. S1P specifically bound to the histone deacetylases HDAC1 and HDAC2 and inhibited their enzymatic activity, preventing the removal of acetyl groups from lysine residues within histone tails. SphK2 associated with HDAC1 and HDAC2 in repressor complexes and was selectively enriched at the promoters of the genes encoding the cyclin-dependent kinase inhibitor p21 or the transcriptional regulator c-fos, where it enhanced local histone H3 acetylation and transcription. Thus, HDACs are direct intracellular targets of S1P and link nuclear S1P to epigenetic regulation of gene expression.

[1]  E. Olson,et al.  The many roles of histone deacetylases in development and physiology: implications for disease and therapy , 2009, Nature Reviews Genetics.

[2]  A. Sharrocks,et al.  MAP Kinase-Mediated c-fos Regulation Relies on a Histone Acetylation Relay Switch , 2008, Molecular cell.

[3]  E. Albi,et al.  Phosphatidylcholine/sphingomyelin metabolism crosstalk inside the nucleus. , 2008, The Biochemical journal.

[4]  E. Seto,et al.  The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men , 2008, Nature Reviews Molecular Cell Biology.

[5]  J. Cyster,et al.  Finding a way out: lymphocyte egress from lymphoid organs , 2007, Nature Immunology.

[6]  S. Milstien,et al.  Involvement of sphingosine kinase 2 in p53-independent induction of p21 by the chemotherapeutic drug doxorubicin. , 2007, Cancer research.

[7]  P. Marks,et al.  Histone Deacetylase Inhibitors: Overview and Perspectives , 2007, Molecular Cancer Research.

[8]  Huan Yu,et al.  Protein Kinase D-mediated Phosphorylation and Nuclear Export of Sphingosine Kinase 2* , 2007, Journal of Biological Chemistry.

[9]  S. Milstien,et al.  Sphingosine Kinase Type 2 Activation by ERK-mediated Phosphorylation* , 2007, Journal of Biological Chemistry.

[10]  S. Milstien,et al.  Functions of the Multifaceted Family of Sphingosine Kinases and Some Close Relatives* , 2007, Journal of Biological Chemistry.

[11]  S. Payne,et al.  A rapid and sensitive method to measure secretion of sphingosine-1-phosphate. , 2007, Methods in enzymology.

[12]  L. Mahadevan,et al.  Enhanced histone acetylation and transcription: a dynamic perspective. , 2006, Molecular cell.

[13]  Hugh Rosen,et al.  Lysophospholipid receptors as potential drug targets in tissue transplantation and autoimmune diseases. , 2006, Current pharmaceutical design.

[14]  S. Minucci,et al.  Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer , 2006, Nature Reviews Cancer.

[15]  L. Ngo,et al.  Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Sarah Spiegel,et al.  Sphingosine-1-phosphate: an enigmatic signalling lipid , 2003, Nature Reviews Molecular Cell Biology.

[17]  R. Irvine Nuclear lipid signalling , 2003, Nature Reviews Molecular Cell Biology.

[18]  D. O’Carroll,et al.  Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression , 2002, The EMBO journal.

[19]  S. Milstien,et al.  Molecular Cloning and Functional Characterization of a Novel Mammalian Sphingosine Kinase Type 2 Isoform* , 2000, The Journal of Biological Chemistry.

[20]  P. Marks,et al.  Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors , 1999, Nature.

[21]  J. Ashby References and Notes , 1999 .

[22]  L. Cocco,et al.  Phospholipid interactions in rat liver nuclear matrix. , 1980, Biochemical and biophysical research communications.